Log in

NYSE:CGCCanopy Growth Stock Price, Forecast & News

$19.42
+1.17 (+6.41 %)
(As of 05/25/2020 03:37 PM ET)
Add
Compare
Today's Range
$17.60
Now: $19.42
$19.48
50-Day Range
$13.25
MA: $15.19
$18.25
52-Week Range
$9.00
Now: $19.42
$45.78
Volume14.00 million shs
Average Volume7.31 million shs
Market Capitalization$6.81 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.62
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Read More
Canopy Growth logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
Phone855-558-9333

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$170.25 million
Book Value$16.03 per share

Profitability

Net Income$-522,300,000.00
Net Margins-535.05%

Miscellaneous

Employees3,200
Market Cap$6.81 billion
Next Earnings Date5/29/2020 (Confirmed)
OptionableOptionable

Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Canopy Growth (NYSE:CGC) Frequently Asked Questions

How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CGC stock has increased by 45.5% and is now trading at $19.42. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Canopy Growth?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 13 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Canopy Growth.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, May 29th 2020. View our earnings forecast for Canopy Growth.

How can I listen to Canopy Growth's earnings call?

Canopy Growth will be holding an earnings conference call on Friday, May 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for CGC?

23 equities research analysts have issued 1-year target prices for Canopy Growth's stock. Their forecasts range from $15.60 to $107.57. On average, they anticipate Canopy Growth's share price to reach $37.74 in the next year. This suggests a possible upside of 94.4% from the stock's current price. View analysts' price targets for Canopy Growth.

Has Canopy Growth been receiving favorable news coverage?

News stories about CGC stock have been trending somewhat positive on Monday, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Canopy Growth earned a news sentiment score of 1.5 on InfoTrie's scale. They also assigned press coverage about the marijuana producer a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutCanopy Growth.

Who are some of Canopy Growth's key competitors?

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Aurora Cannabis (ACB), Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), KushCo (KSHB) and Aurora Cannabis (ACB).

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
  • Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
  • Mr. Timothy Rob Saunders, Exec. Officer
  • Mr. Rade Kovacevic, Exec. VP
  • Mr. Mike Lee, Acting Chief Financial Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by many different retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (0.74%), CIBC World Markets Inc. (0.40%), The Manufacturers Life Insurance Company (0.30%), Morgan Stanley (0.28%), Swiss National Bank (0.23%) and Legal & General Group Plc (0.22%).

Which institutional investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, ETF Managers Group LLC, Toronto Dominion Bank, Commerzbank Aktiengesellschaft FI, Canada Pension Plan Investment Board, Janus Henderson Group PLC, Cambridge Investment Research Advisors Inc., and Kingsview Wealth Management LLC.

Which institutional investors are buying Canopy Growth stock?

CGC stock was bought by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Advisor Group Holdings Inc., Swiss National Bank, V Wealth Advisors LLC, Atom Investors LP, Parametric Portfolio Associates LLC, Valeo Financial Advisors LLC, and Verde Capital Management.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $19.42.

How big of a company is Canopy Growth?

Canopy Growth has a market capitalization of $6.81 billion and generates $170.25 million in revenue each year. The marijuana producer earns $-522,300,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. Canopy Growth employs 3,200 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A 0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.